文献速递心脏核医学

静脉输注100毫升脂肪乳显著改善心脏FDG PET心肌葡萄糖代谢抑制

An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该前瞻性研究纳入58例因心肌炎症、心内膜炎、心脏或心旁肿块、心内装置或人工瓣膜感染而行FDG PET/CT的患者,比较在髙脂低碳水化合物饮食(HFLCD)基础上加用静脉100毫升脂肪乳输注与单用HFLCD的效果。结果显示脂肪乳组心肌FDG摄取评分0的比例(89% vs 63%,P=0.021)和可解读图像率(100% vs 72%,P=0.0047)均显著提高,所有心肌SUV值均降低。

要点

  • HFLCD基础上加用静脉100毫升脂肪乳可显著提高心肌FDG摄取完全抑制率。
  • 脂肪乳组可解读图像率100%,显著高于单用HFLCD组的72%。
  • 脂肪乳组心肌SUVmax中位数1.9,显著低于对照组的3.1。

核心结论

  • 在HFLCD基础上加用静脉脂肪乳输注比单用HFLCD能更好地抑制心脏葡萄糖代谢。

研究设计与样本

  • 前瞻性研究连续纳入58例患者,其中28例接受脂肪乳输注,30例为单用HFLCD的对照。
  • 脂肪乳组在成像前3小时静脉输注100毫升脂肪乳,所有患者至少2餐HFLCD后禁食至少6至12小时。
  • 纳入患者因心肌炎症、心内膜炎、心脏或心旁肿块、心内装置或人工瓣膜感染而转诊行FDG PET/CT。

主要发现

  • 脂肪乳组心肌FDG摄取评分0(完全抑制)的比例为89%,显著高于对照组的63%(P=0.021)。
  • 脂肪乳组根据临床指征可解读图像率为100%,显著高于对照组的72%(P=0.0047)。
  • 脂肪乳组所有心肌SUV值均降低,例如SUVmax中位数为1.9(四分位距1.7-2.5),对照组为3.1(四分位距2.3-4.1),P<0.001。

关键数值与推荐

  • 心肌FDG摄取评分从0(完全心肌抑制)到3(高弥漫性摄取)。
  • 脂肪乳组评分0比例为89%,对照组为63%(P=0.021)。
  • 脂肪乳组可解读图像率为100%,对照组为72%(P=0.0047)。
  • 脂肪乳组心肌SUVmax中位数为1.9(四分位距1.7-2.5),对照组为3.1(四分位距2.3-4.1),P<0.001。

临床怎么用

  • 对于需行心脏FDG PET/CT评估心肌炎症、感染或肿瘤的患者,可在HFLCD基础上加用静脉100毫升脂肪乳输注以改善心肌葡萄糖代谢抑制。
  • 加用脂肪乳输注可提高图像可解读率,减少因生理性心肌FDG摄取导致的诊断困难。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Physiological myocardial accumulation of FDG impairs the diagnosis of inflammatory/infectious or tumoral myocardial detection by FDG PET/CT. We prospectively evaluated the addition, 3 hours before imaging, of an intravenous 100-mL lipid emulsion infusion (Intralipid) to a high-fat, low-carbohydrate diet (HFLCD) for at least 2 meals followed by a fast of at least 6 to 12 hours in patients referred for the diagnosis of myocardial inflammation, endocarditis, cardiac or paracardiac masses, intracardiac device, or prosthetic valve infections. METHODS: Data of 58 patients consecutively included (28 Intralipid patients, 30 controls with HFLCD alone) were compared. FDG uptake in normal myocardium was scored from 0 (complete myocardial suppression) to 3 (high diffuse uptake). Myocardial maximal, peak, and mean SUV and the rate of interpretable images according to the clinical indication were measured. RESULTS: Compared with controls, Intralipid infusion significantly improved the rate of score 0 (89% vs 63%, P = 0.021), of interpretable images according to the clinical indication (100% vs 72%, P = 0.0047) and decreased all myocardial SUV values (eg, SUVmax median, 1.9 [interquartile range, 1.7-2.5] vs 3.1 [interquartile range, 2.3-4.1]; P < 0.001). CONCLUSIONS: A lipid emulsion infusion in addition to HFLCD better suppresses cardiac glucose metabolism than HFLCD alone.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dietz M, Paulmier B, Berthier F, et al. An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice. Clin Nucl Med. 2021. PMID: 33630808. doi:10.1097/RLU.0000000000003556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。